https://www.selleckchem.com/pr....oducts/pepstatin-a.h
2 vs. 0%, P less then 0.05). No severe HBO-related adverse effects were observed. In conclusion, HBO is a feasible option for treating viral HC after allogeneic HSCT. The risk of contrast-induced nephropathy (CIN) is high in patients with chronic kidney disease (CKD). However, the mechanism of CIN in CKD is not fully understood. Here, we prepared a clinically relevant model of CIN and examined the role of necroptosis, which potentially cross-talks with autophagy, in CIN. In Sprague-Dawley rats, CKD was induced by subtotal nephrect
Like
Comment
Share
